2
Announcements
Trials
Browse
Landscape
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
CNS
1
Conditions
Brain Neoplasms
12
Cognitive Dysfunction
4
Radiation Injuries
3
Neoplasms
3
Multiple Myeloma
3
Glioma
3
Breast Neoplasms
3
Lymphoma, B-Cell
2
Lymphoma
2
Glioblastoma
2
Fatigue
2
Colorectal Neoplasms
2
Astrocytoma
2
Triple Negative Breast Neoplasms
1
Stroke
1
Sarcoma
1
Prostatic Neoplasms
1
Pituitary Neoplasms
1
Parkinson Disease
1
Osteosarcoma
1
Oligodendroglioma
1
Neurotoxicity Syndromes
1
Neurofibromatosis 1
1
Neuroendocrine Tumors
1
Neoplasm Metastasis
1
Meningioma
1
Medulloblastoma
1
Lymphoma, Non-Hodgkin
1
Lymphoma, Large B-Cell, Diffuse
1
Lymphoma, B-Cell, Marginal Zone
1
Interventions
fluorodopa F 18
2
Tomography, Emission-Computed, Single-Photon
1
Registries
1
Positron Emission Tomography Computed Tomography
1
Neuropsychological Tests
1
Neurofeedback
1
Medical Marijuana
1
Iodine-124
1
Iodine-123
1
Furosemide
1
Exergaming
1
Clinical Laboratory Techniques
1
4-chloro-N-(2-furylmethyl)-5-sulfamoylanthranilic acid
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Parkinson Disease
×
Neuropsychological Tests
×
Clear all
NCT05791006
2023-03-30
NEUROFIN
Istituto Auxologico Italiano
Unknown
99 enrolled